Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
AstraZeneca makes surprise U-turn with £300m pharma investment in UK
Britain's biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year. The drugmaker had pulled back projects in Britain after becoming disillusioned with the…
Court sentences Purdue Pharma to pay $5.5B, clearing settlement path
April 28 (UPI) -- A federal judge on Tuesday sentenced Purdue Pharma to pay more than $5 billion in criminal penalties, clearing the way for the OxyContin maker to complete its bankruptcy settlement agreement and resolve thousands of opioid-related…
OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
A federal judge sentenced OxyContin manufacturer Purdue Pharma on Tuesday, ordering the company to pay over $5 billion in criminal penalties. The pharmaceutical company will soon dissolve, as the sentencing was the last step before Purdue Pharma…
Purdue Pharma to Pay $225 Million to Justice Department
A federal judge has sentenced OxyContin maker Purdue Pharma to pay the government $225 million, ending the government's yearslong criminal case and allowing the pharmaceutical company accused of fueling the opioid epidemic to wrap up a settlement…
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
Britain's largest drugmakers saw 2026 get off on a positive note, with AstraZeneca and GSK both reporting core earnings ahead of expectations on Wednesday The CEOs of a number of European pharma giants have recently said that Europe risks losing…
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Drew Angerer | Getty Images News | Getty Images OxyContin maker Purdue Pharma was sentenced on Tuesday to $5.5 billion in fines and penalties stemming from its 2020 guilty plea to charges of deceiving government regulators and paying kickbacks to…
Judge OKs OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves
NEWARK, N.J. — OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on…
US opioid crisis victims testify at emotional Purdue Pharma hearing
Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to government data. Purdue and other opioid makers and distributors are accused of aggressively marketing prescription painkillers like…
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
MUMBAI, India, April 28, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and…
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
Seth Wenig People rally outside a courthouse while a hearing for Purdue Pharma takes place inside in Newark, N.J., Tuesday, April 21, 2026. (AP Photo/Seth Wenig) Updated: 8:24 PM EDT Apr 28, 2026 OxyContin maker Purdue Pharma set to dissolve after…
Sun Pharma puts in place team to integrate Organon global operations
Days after Sun Pharmaceutical Industries announced its $ 11.75 billion deal to acquire United States-based healthcare company Organon – the Indian drugmaker is putting in place a team to oversee the integration of Organon's global…
Piramal Pharma sees strong growth ahead on rising demand for cancer therapies
India's Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex drugs, including targeted cancer therapies, a top executive said on Wednesday. The company, which…
HC Wainwright Predicts Weaker Earnings for BridgeBio Pharma
BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Equities researchers at HC Wainwright cut their Q2 2026 earnings per share estimates for shares of BridgeBio Pharma in a research…
aTyr Pharma (ATYR) Projected to Post Earnings on Wednesday
aTyr Pharma (NASDAQ:ATYR - Get Free Report) will likely be announcing its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors may visit the…
Massive Miller House campaign fundraising lead draws from fossil fuel, pharma support
Rep. Carol Miller, R-W.Va., has built a massive campaign fundraising advantage in her bid for a fifth term in the U.S. House of Representatives, driven by contributions from political action committees for health care and fossil fuel energy…
Receive a Daily briefing on Pharma Industry News
Get Started